Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of COX-2 in breast and cervical cancer.

× No keyword cloud information.

7 in total

Review 1. Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors: Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal: Endocr Pathol Date: 2005 Impact factor: 3.943

2. Lack of association between cyclooxygenase 2-765G/C gene polymorphism and breast cancer risk in Ahvaz, west-south Iran.

Authors: Behnaz Ahmadi; Abdolrahim Nikzamir; Seid Mohamadali Ghafari; Ghorban Mohamadzadeh; Mahmod Latifi; Ahmad Bafandeh; Mohammad Fathi; Mir Saeed Yekaninejad; Mahfam Nikzamir
Journal: Mol Biol Rep Date: 2014-01-09 Impact factor: 2.316

3. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.

Authors: John Kwagyan; Victor Apprey; Hassan Ashktorab
Journal: Clin Transl Sci Date: 2012-01-10 Impact factor: 4.689

4. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.

Authors: Jing Shen; Marilie D Gammon; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal: Breast Cancer Res Date: 2006 Impact factor: 6.466

The role of COX-2 in breast and cervical cancer.

Review 1. Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

2. Lack of association between cyclooxygenase 2-765G/C gene polymorphism and breast cancer risk in Ahvaz, west-south Iran.

3. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.

4. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.

5. COX-2 Expression in Breast Carcinoma with Correlation to Clinicopathological Parameters

6. Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas.

7. COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ.